For citation:
Makatsariya A.D., Di Renzo G.C., Rizzo G., Bitsadze V.O., Khizroeva J.Kh., Blinov D.V., Vovk E.I., Govorov I.E., Guryev D.L., Dikke G.B., Zainulina M.S., Zakharova N.S., Kovalev V.V., Komlichenko E.V., Kramarskiy V.A., Loginov A.B., Maltseva L.I., Nemirovskiy V.B., Ponomarev D.A., Rudakova E.B., Samburova N.V., Serova O.F., Tetelyutina F.K., Tretyakova M.V., Ungiadze J.Yu., Tsibizova V.I. Regarding the evidence-based use of micronized progesterone. Obstetrics, Gynecology and Reproduction. 2020;14(3):374-383. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.171
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
